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The aim of this study was to evaluate the DNA damage and repair in kidney cells of Swiss albino mice after repeated 
exposure to sevoflurane and isoflurane and compare their detrimental effects. We used the alkaline comet assay to establish 
the genetic damage and measured three parameters: tail length, tail moment, and tail intensity of comets. These parameters 
were measured immediately after exposure to the above mentioned inhalation anaesthetics, two hours, six hours, and 24 
hours later and were compared with the control group. Mean values of all three parameters were significantly higher in 
experimental groups compared to the control group. DNA damage in kidney cells of mice exposed to sevoflurane increased 
continuously before it reached its peak 24 hours after exposure. Isoflurane induced the highest DNA damage two hours 
after exposure. Levels of DNA damage recorded 24 h after cessation of exposure to both tested compounds suggest that 
sevoflurane was slightly more genotoxic than isoflurane to kidney cells of mice. According to these results, the currently 
used volatile anaesthetics sevoflurane and isoflurane are able to damage DNA in kidney cells of mice. Such findings 
suggest a possibility for similar outcomes in humans and that fact must be taken into account in everyday clinical practice.
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The halogenated volatile anaesthetics sevoflurane and 
isoflurane are the most widely used volatile anaesthetics in 
clinical practice providing dose-dependent amnesia, 
sedation, and hypnosis sufficient for surgical procedures 
(1). These potent anaesthetics are liquids at room 
temperature and atmospheric pressure but they have 
propensity to move from liquid to gas phase due to their 
high vapour pressure (1). Although the mechanism of action 
of volatile anaesthetics is complex, likely involving 
numerous membrane proteins and ion channels, it is clear 
that producing their ultimate effect depends on the 
attainment of the therapeutic tissue concentration in the 
central nervous system (2). Because of the large pulmonary 
surface area, access to circulation is rapid, as are their 
pharmacologic effects. They are almost instantaneously 
absorbed through the respiratory epithelium and mucous 
membranes of the respiratory tract into the blood avoiding 
hepatic first pass metabolism (3).
Although volatile anaesthetics are delivered and 
primarily eliminated via lungs (3), they undergo oxidative 
metabolism by cytochrome P450 enzymes in the liver, 
kidney, and lungs. Isoflurane is metabolised to a lesser 
extent (0.2 %) than sevoflurane (5%). Biotransformation 
has a little effect on the pharmacologic activity of 
anaesthetics but it may have a significant effect on the 
toxicity of these agents (3). The metabolism of certain 
inhaled halogenated anaesthetics can produce inorganic 
fluoride that may be directly nephrotoxic (3). Sevoflurane 
metabolism results in the highest serum fluoride ion level 
of current anaesthetics. In spite of that, clinical signs of 
nephrotoxicity do not occur even when sevoflurane is 
administered for prolonged periods in low-flow breathing 
systems. 
Comparing the genotoxicity of sevoflurane and 
isoflurane in patient's peripheral blood lymphocytes during 
and after anaesthesia using comet assay showed that both 
anaesthetics have a potent genotoxic effect. The effect is at 
its peak 120 minutes after anaesthesia and DNA repair 
activity starts on the third day after anaesthesia. It reaches 
its completion on the fifth day (4). Alleva et al. (5) 
investigated the genotoxicity of sevoflurane on DNA of 
peripheral lymphocytes immediately following anaesthesia 
and 24 hours after surgery. Genotoxicity was evaluated by 
assaying DNA damage, DNA repair enzyme activity, 
apoptosis and GSH (plasma glutathione) content in 
peripheral lymphocytes isolated from 20 patients undergoing 
orthopaedic surgery. DNA strand breaks occurred on the 
first post-operative day but 24 hours after the surgery most 
of the oxidised DNA bases were repaired. The comet assay 
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was used to prove the potential genotoxicity of inhalation 
anaesthetics in human peripheral blood lymphocytes (6, 7). 
This simple method enables a sensitive detection of primary 
DNA damage in single eukaryotic cells (8). It presents 
several significant advantages over other commonly used 
genotoxicity assays. This assay has previously been 
formally validated in order to represent the standardised 
protocol with acceptability by international regulatory 
agencies (9). 
The DNA injury estimated in peripheral blood 
lymphocytes during anaesthesia with sevoflurane and 
isoflurane demonstrated an increased mean comet migration 
at two hours following anaesthesia and the cells repaired 
completely on the fifth postoperative day (4). Sardas et al. 
(6) reported similar results with isoflurane anaesthesia. On 
the other hand, Szyfter et al. (7) concluded that sevoflurane 
did not have genotoxic effects both in vitro and in vivo. 
Furthermore, DNA damage of mouse cells, investigated by 
the alkaline comet assay and micronucleus test, was 
significant and none of the tested tissues showed signs of 
repair until 24 hours after the exposure to sevoflurane (10). 
Rozgaj et al. (11, 12) reported the genetic damage induced 
by anaesthetic gases in occupationally exposed population. 
The existing knowledge regarding the nephrotoxic 
potential of sevoflurane and isoflurane is still incomplete. 
Most studies focused on functional renal impairments and 
nephrotoxicity but did not investigate the adverse effects 
at the cell level. The aim of our study was to highlight the 
genotoxic damage and repair in kidney cells of Swiss albino 
mice during the first 24 hours after repeated exposure to 
sevoflurane and isoflurane and to compare their detrimental 
effects using the alkaline comet assay. 
MATERIALS AND METHODS
Animal studies and experimental procedure
The animal study was designed in accordance with the 
relevant Croatian guidelines: Animal Protection Act (13) 
and the Ordinance on the protection of animals used for 
scientific purposes (14). It was also approved by the Ethical 
Committee of the Faculty of Science and Medical School 
(University of Zagreb, Croatia). 
Inhalation anaesthetic sevoflurane (1-chloro-2,2,2-
trifluoroethyl difluoromethyl ether, CHF2OCHClCF3; 
Sevorane) and isoflurane (iso-1,1,1,3,3,3-hexafluoropropyl 
fluoromethyl ether, CH2FOCH[CF3]2); Forane) were 
provided by Abbott Laboratories LTD (Queenborough, 
UK). A total of 45 Swiss albino male mice (three months 
old, body weight approximately 20-25 grams) were obtained 
from the breeding unit of the Department of Biology, 
Faculty of Science, University of Zagreb, Croatia. The 
animals were housed at 22 ± 1°C and 50-70 % humidity 
with a 12/12 hours light/dark cycle photoperiod. They were 
receiving standard laboratory diet (4 RF 21, Mucedola s.r.l., 
Italy) and water ad libitum. 
Anaesthesia was maintained with sevoflurane 
(2.4 vol %) or isoflurane (1.7 vol %) in a continuous flow 
of a 50:50 mixture of oxygen and air (3 L min-1) in a 
specially designed induction chamber connected to an 
anaesthetic machine (Sulla 800; Dräger) using a compatible 
evaporator. The fresh gas was flowing in one direction, 
without rebreathing and exhaled gases were released 
through the exhaust pipe into the atmosphere. Nitrous oxide 
was not used in anaesthesia in order to avoid additional 
DNA lesions. The depth of anaesthesia was considered 
satisfactory when mice were sleeping calmly, breathing 
spontaneously, and not wiggling their tail. 
The animals were divided into eight experimental 
groups and corresponding non-treated controls. Each group 
consisted of five mice. Experimental groups of mice were 
exposed to sevoflurane (2.4 vol %) or isoflurane (1.7 vol %) 
during two hours for three consecutive days. Following 
termination of exposure, mice were sacrificed by cervical 
dislocation at four time points: immediately after 
administration of third anaesthesia (0 h), and two, six, and 
24 h afterwards. Kidneys were dissected and samples of 
cells were collected for further analysis. 
If not specified, chemicals and reagents were purchased 
form from Sigma-Aldrich Chemical Co. (St. Louis, MO, 
USA).
The comet assay
Kidney tissues were collected, minced, and passed 
through a stainless steel mash and single-cell suspensions 
were made in the homogenisation buffer solution cooled to 
4 °C (0.075 M NaCl and 0.024 M Na2 EDTA; pH 7.5), at 
the ratio 1 g tissue / 1 mL buffer). The comet assay was 
carried out under alkaline conditions, as described by Singh 
et al. (15). Two slides per animal were prepared. Agarose 
gels were prepared on fully frosted slides coated with 1 % 
and 0.6 % normal melting point (NMP) agarose (Sigma). 
Six microliters of freshly prepared kidney cell suspensions 
were mixed with 0.5 % low melting point (LMP) agarose 
(Sigma) placed onto precleared microscope slides and 
covered with 0.5 % LMP agarose. The slides were immersed 
for two hours in a freshly prepared ice-cold lysis solution 
(2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris-HCl, 1 % 
sodium sarcosinate (Sigma), pH 10, with 1 % Triton X-100 
(Sigma) and 10 % dimethyl sulfoxide (Kemika, Zagreb, 
Croatia). Denaturation and electrophoresis were carried out 
at 4 °C under dimmed light in a freshly prepared 
electrophoresis solution (300 mM NaOH, 1 mM Na2 EDTA, 
pH 13). After 20 min of denaturation, the slides were 
randomly placed in a horizontal gel-electrophoresis unit, 
facing the anode. After the unwinding of DNA, 
electrophoresis was carried out in the alkaline solution for 
20 min at 25 V (300 mA). Electrophoresis at high pH results 
in structures resembling comets, as observed by fluorescence 
microscopy; the intensity of the comet tail relative to the 
head reflects the number of DNA breaks. After 
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electrophoresis, the slides were neutralised by adding Tris 
buffer (0.4 M Tris-HCl, pH 7.5) three times at five minute 
intervals. Images of 100 randomly selected cells (50 counts 
on each duplicate slide) were analysed for each sample 
(animal). The slides were stained with ethidium bromide 
(20 µg mL-1) and examined under magnification 250x, using 
an epifluorescence microscope (Leitz, Germany). The 
microscope was connected through a camera to a computer-
based image analysis system (Comet Assay IV software, 
Perspective Instruments Ltd., Suffolk, UK). A total of 500 
kidney cells from each group were analysed. Comets were 
randomly captured at a constant depth of the gel, avoiding 
the edges of the gel, occasional death cells, and superimposed 
comets. Comet analysis was performed on coded slides by 
one reader to avoid variability due to subjective scoring. 
DNA damage was determined as the tail length (distance 
of DNA migration from the centre of the body of the nuclear 
core, expressed in µm), tail intensity (percentage of genomic 
DNA that migrated during the electrophoresis from the 
nuclear core to the tail), and tail moment (product of the 
tail length and the fraction of total DNA in the tail). 
Statistical analysis
Statistical analysis was performed by using Statistica 
5.0 software (Statsoft, Tulsa, USA). Descriptive statistics 
was calculated. Analysis of variance (ANOVA) was selected 
for testing the effects of sevoflurane and isoflurane. The 
data obtained with the alkaline comet assay were first 
logarithmically transformed to normalise the distribution 
and equalise variances. Multiple comparisons between 
groups were tested using a post-hoc Tukey honest significant 
difference (HSD) test. The level of statistical significance 
was set at P<0.05.
RESULTS 
Results regarding the primary DNA damage levels in 
kidney cells of mice measured by the alkaline comet assay 
and detailed explanations of their statistical significance are 
presented in Table 1. The values of all comet parameters 
measured in kidney cells observed immediately after the 
last exposure to sevoflurane showed that the DNA damage 
was minor and not significantly increased in comparison 
with the control group. However, the values recorded at the 
time-points two hours, six hours, and 24 h after cessation 
of sevoflurane exposure suggest a clear genotoxic effect of 
the tested compound. In all experimental groups, DNA 
damage levels in kidney cells were significantly different 
(P<0.05) vs. control group. 
All isoflurane exposed groups revealed a statistically 
significant (P<0.05) increase of comet parameter values 
compared to control. Contrary to sevoflurane, the repeated 
exposure to isoflurane immediately caused a significant 
increase in the comet parameters values and the highest 
level of primary DNA damage was measured two hours 
after the treatment. After six and 24 hours, DNA damage 
in kidney cells exposed to isoflurane slowly decreased but 
it did not return to the level of the control group. 
It is noteworthy to mention that the level of primary 
DNA damage in kidney cells of isoflurane-exposed mice 
two hours after the treatment cessation was almost four-fold 
higher compared to the DNA damage observed in rats given 
sevoflurane treatment (Table 1), which was statistically 
significant. 
However, the values recorded 24 h after the cessation 
of exposure to both tested compounds suggest that 
sevoflurane was slightly more genotoxic than isoflurane to 
kidney cells of mice, which is supported by higher values 
of all three studied comet parameters.
Taken together, our comet assay results suggest a 
possibility that sevoflurane should be considered a more 
potent inducer of more complex DNA damage, whose repair 
took more than 24 h, while isoflurane caused immediate 
increase of simple forms of DNA, which was mostly 
repaired within the first six hours after the cessation of 
exposure. 
DISCUSSION
In spite of the extensive research conducted so far, both 
in vivo on animal models or in clinical studies with patients 
anaesthetised with sevoflurane and isoflurane, toxicity 
profiles of these compounds remain controversial. The 
present study intended to fill the existing gap in the 
knowledge by adding information on the levels of primary 
DNA lesions detected in the mice kidney following 
exposure to these frequently used inhalation anaesthetics. 
In comparison with previous studies, which mostly focused 
on functional renal impairments and nephrotoxicity (16-20), 
here we studied the level of primary DNA damage in single 
kidney cells. Taking into account that the majority of 
primary DNA lesions detectable using the alkaline comet 
assay are potentially repairable, our results mostly indicate 
the acute effects caused by the tested compounds, and also 
suggest the differences in their ability to destabilise the 
integrity of DNA in kidney cells of mice. It is noteworthy 
to mention here that the alkaline comet assay we used allows 
a sensitive detection of different forms of primary DNA 
damage in single cells but the most important among them 
are DNA strand breaks and alkali-labile sites (8, 21-23).    
According to our results, both tested compounds were 
able to induce primary DNA damage in kidney cells of 
Swiss albino mice detectable using the alkaline comet assay. 
What we clearly showed was that sevoflurane and isoflurane 
differed in their capacities to produce measurable DNA 
damage and that their repair dynamics differed as well. It 
has to be mentioned that primary DNA damage measured 
in kidney cells after either treatment did not return to the 
values measured in the control group. Thus, 24 hours was 
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not long enough time to remove all the lesions inflicted by 
both treatments in DNA. 
It is interesting to stress here that when tail length 
parameter was taken into account, sevoflurane exposure 
caused a steadily increase in DNA damage across the time 
points studied. Isoflurane exposure, on the other hand, 
resulted in the maximum tail length measured at time point 
two hours, which decreased at later time points. However, 
when tail intensities were taken into account, sevoflurane 
treatment resulted in a significant drop of DNA content in 
comet tails two hours after exposure cessation (which was 
even lower than in the control), while later on this value 
continued to increase. Isoflurane exposure, in contrast, did 
not result in such immense drop of the DNA content in 
comet tails at the same time point. 
Such findings emphasise the need for a concurrent 
evaluation of the tail length and tail intensity parameters to 
prevent erroneous conclusions regarding the overall primary 
DNA damage measured by the comet assay. If our 
conclusions were based only on the tail length, one could 
overlook the time point, which was an important element 
for the repair of sevoflurane induced primary DNA damage. 
A detailed analysis, which included both tail length and 
tail intensity, showed that during the post-exposure time 
the amount of DNA breaks induced by complex repair 
processes in kidney cells of sevoflurane-treated mice 
increased. This was obviously due to the formation of 
additional breaks in DNA, which was subjected to repair 
processes. These breaks represent an indirect DNA damage, 
which contributes to the overall increase in comet tail 
parameters.
Different DNA damage levels measured by the alkaline 
comet assay after sevoflurane and isoflurane exposure could 
be the result of several issues. Among these, the most 
important are their availability, lipid solubility, stability, 
biotransformation/metabolism, and different capability to 
produce oxidative stress. As known, sevoflurane undergoes 
much more extensive metabolism than isoflurane (24), 
which evidently contributed to the amount of reactive 
compounds with DNA damaging properties. Previous 
studies suggest that in humans 2-5 % of the absorbed dose 
of sevoflurane is metabolised, compared to only 0.2 to 2 % 
of isoflurane (3, 25). Second, it is important to mention that 
sevoflurane biotransformation results in the formation of 
inorganic fluoride and the so-called compound A, which 
are both considered toxic and, especially, nephrotoxic (25, 
26). Goldberg et al. (27) found that sevoflurane 
biotransformation resulted in the generation of greater 
amounts of fluoride ions than isoflurane. As known, 
sevoflurane metabolism occurs predominantly in the liver 
by cytochrome P450 2E1 isoenzyme (3) but its extrahepatic 
metabolism is also present, which strongly influenced its 
nephrotoxicity (19). Sevoflurane metabolism is also 
associated with the formation of reactive products, which 
could directly trigger the generation of peroxynitrite and 
































































































































































































































































































































































































































































































































































































































































































































been previously related to the generation of reactive oxygen 
species (28). Another important fact, which has to be 
mentioned, is that compound A may be an alkylating agent 
(4, 17). This could explain why we observed an increase in 
damage levels using the alkaline comet assay at time points 
six and 24 h, considering that DNA lesions induced by the 
alkylating agents in general require the involvement of more 
complex repair systems (29, 30), than the “simple” types 
of DNA damage as strand breaks or alkali labile sites, which 
are usually repaired within few hours after infliction. 
A limited number of studies has investigated DNA 
damage in lymphocytes, brain, liver, and kidney cells of 
animals repeatedly exposed to sevoflurane (31). Although 
sevoflurane was able to induce genetic lesions in vivo, the 
DNA damage seems to be repaired within the upcoming 
days of the last exposure. These studies have used different 
animal models and species, different times of exposure and 
routes, different doses and different time points besides a 
variety of other possible confounding factors such as 
temperature, hemodynamic data, and air flow rate, making 
the comparison among the reports very difficult (31). 
Furthermore, our previous study evaluated genetic damage 
in leukocytes, in the liver, kidney, and brain cells in vivo 
(10, 32) but none of the observed tissues revealed signs of 
repair until 24 h after the exposure to sevoflurane (32). 
Isoflurane was in previous studies mostly reported not 
as toxic as sevoflurane and possessing much lower 
nephrotoxic potential, while the reports regarding its 
genotoxicity are controversial. Sardas et al. (6) studied the 
levels of DNA damage in patients anesthetised with 
isoflurane and observed slight genotoxic effects in 
lymphocytes, which effectively repaired within five days 
following exposure. Kim et al. (24) in their comet assay 
study reported that isoflurane exposure resulted in 
significant DNA damage in lymphocytes, bone marrow, 
spleen, brain, liver, and lung of rats. Although in rats 
exposed to isoflurane for 60 min an increase in oxidative 
stress parameters such as lipid and protein oxidation was 
observed, the authors could not show evidence of the 
association between DNA damage and oxidative stress 
parameters. According to Braz et al. (33), exposure of 
patients to isoflurane did not induce genotoxicity and 
cytotoxicity in lymphocytes and in their leukocytes, 
although genetic repair and apoptosis-related genes were 
down-regulated on the first post-operative day (33). 
Taken together, we presume that different levels of DNA 
damage in kidney cells could be related both to direct action 
of the tested compounds on DNA but also to different level 
of oxidative stress caused by the treatment. In this view, 
sevoflurane seems to be a more effective producer of 
oxidative stress than isoflurane. In sevoflurane treated 
human leukocytes, a dose-dependent oxidative stress and 
cellular injury, especially apoptosis, were observed (28, 
34). Rocha et al. (35) provided evidence that sevoflurane 
induced genetic damage, whereas isoflurane increased 
systemic antioxidative status in Wistar rats exposed for 
120 min. They suggest that possible mechanisms of 
sevoflurane genotoxicity include direct genotoxicity and/
or oxidative route by metabolism (35). Clinical studies 
indicated the absence of systemic DNA damage or oxidative 
DNA damage in patients under isoflurane anaesthesia (33). 
In patients undergoing minimally invasive surgery under 
isoflurane anaesthesia, a slight increase in the plasma's 
antioxidant capacity was observed (33). A positive effect 
of isoflurane in the protection of cardiomyocytes from 
damage by oxidative stress has also been proven by 
Marinovic et al. (36). These authors underscore the 
importance of sarcolemmal and mitochondrial adenosine 
ariphosphate- (ATP-) sensitive potassium channels in the 
protection. Hirata et al. (37) proved that isoflurane reduced 
myocardial infarction size by modulating mitochondrial 
ROS at clinical concentrations. Rocha et al. (35) showed 
that rats anesthetised with isoflurane had a higher plasma 
antioxidative status. Concerning these findings, we presume 
that repair of DNA in rats treated with isoflurane in our 
study could be the consequence of the activation of 
antioxidative mechanisms in kidney cells. 
A few limitations of our approach also merit comment. 
One of the limitations is the selection of exposure design. 
Such exposure design was possible to be established in an 
experiment on the rodent model but it is less likely that in 
the real situation patients would be subjected to three 
operative procedures day after day. Nevertheless, extreme 
life-threatening situations may lead to a similar scenario. 
Furthermore, the results obtained on the animal model 
cannot be always automatically extrapolated to the human 
model. Thus, our results represent a good indicator of 
possible outcomes of the exposure to tested anaesthetics 
but they have to be used with precaution since not all 
features of rat and human organisms are the same.    
What also our comet assay results indicate is that 
amount of DNA damage measured in kidney cells 24 h after 
the termination of exposure to both tested compounds was 
similar if one looks at the median values of the tail intensity 
parameter. This parameter is generally the most important 
one for interpreting the comet assay results. We found that 
at time point 24 h, the median values of tail intensity in rats 
exposed to both tested compounds were near 9 % of DNA 
in the comet tail. This information is important from the 
view of prediction of potential risks associated with the 
exposure to both anaesthetics. We assume that these risks 
were relatively low, taking into account that the existing 
literature on the interpretation of the comet assay results 
suggests that tail intensity of up to 10 % is tolerated even 
in the control cells subjected to the alkaline comet assay 
(8). 
Our results also agree well with the results by Ruxanda 
et al. (20) who evaluated the effects of isoflurane and 
sevoflurane anaesthesia on the kidney structure and function 
in rats and did not find any signs of severe impairments of 
the kidney function. Similar results in elderly patients 
subjected to isoflurane and sevoflurane anaesthesia were 
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reported by Hase et al. (26). Therefore, it seems that DNA 
damage inflicted following exposure to both anaesthetics 
was of transient nature, and it is obviously present in the 
first hours post exposure but is mostly effectively repaired 
later on, without producing severe functional impairments.
Although both tested compounds are in regular use in 
clinical practice, there is a constant need to broaden the 
knowledge on their potential adverse effects, by taking into 
account that the choice of the endpoint used in toxicity 
evaluation also influenced the outcomes observed. Thus, 
the development and refinement of sensitive methods and 
biomarkers at DNA level speak in favour of conducting 
new assessments of the adverse effects of substances which 
are in regular clinical use. In the case of sevoflurane and 
isoflurane, it is particularly important to extend the research, 
since the results of the existing studies are rather 
controversial. 
There are various confounding factors that must be 
evaluated before assessing the risk of volatile anaesthetics 
to humans. Species variations in drug metabolism and 
toxicity, different exposure times and dosages, the flow rate 
(in air or in oxygen), and hypoxia during research procedure 
are some of the important factors that make it very 
complicated to extrapolate accurate conclusions from one 
species to another from in vivo investigations to humans 
(31). Regarding in vivo studies, results depend on different 
experimental designs, the type and duration of surgery, the 
characteristics of patients (age, physical status, associated 
co-morbidities or diseases, and other drugs used during the 
aesthetical procedure) (38).
Considering these facts, the foreknowledge that the 
currently used volatile anaesthetics are able to damage DNA 
in a number of genotoxic and mutagenic testes should be 
considered when calculating the value of the overall toxicity 
of these agents in human population.
In spite of the fact that genotoxicity of sevoflurane and 
isoflurane and their possible mechanisms of action have 
been proposed, much remains to be investigated. It is 
important to know that the protocols used for anaesthesia 
are quite different, making the conclusions and comparisons 
challenging. It is necessary to take into account the 
interference of the anaesthetics with cellular signal 
pathways, gene expression profiles, and genetic mechanisms 
to understand the mechanisms by which volatile anaesthetics 
induce DNA damage. Investigation of the oxidative stress 
mechanism and extension of the time of the study could 
provide new evidence of DNA cells damage during 
anaesthesia protocols, not only for sevoflurane and 
isoflurane but also for other commonly used anaesthetics. 
Therefore, this topic represents an area that is worth 
exploring further.
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Genotoksičnost sevoflurana i izoflurana u bubrežnim stanicama miševa
Cilj ovog istraživanja bio je utvrditi razine oštećenja i oporavak DNA u bubrežnim stanicama Swiss albino miševa nakon 
ponavljanog izlaganja sevofluranu i izofluranu te usporediti genotoksičnost spomenutih anestetika. Razine oštećenja DNA 
procijenjene su metodom alkalnoga komet-testa, u kojem su kao pokazatelji oštećenja DNA korištena sljedeća tri parametra: 
dužina repa kometa, intenzitet repa i repni moment. Uzorci bubrežnog tkiva miševa uzimani su netom nakon izlaganja 
pojedinom inhalacijskom anestetiku, dva sata, šest sati i 24 sata poslije izlaganja. Dobiveni rezultati uspoređeni su s 
vrijednostima izmjerenima u kontrolnim, neizloženim jedinkama. Srednje vrijednosti svih triju parametara izmjerene u 
svim eksperimentalnim skupinama bile su statistički značajno veće u odnosu na kontrolnu skupinu. Razina primarnih 
oštećenja DNA u bubrežnim stanicama miševa izloženih sevofluranu kontinuirano se povećavala unutar 24 sata od 
izlaganja, za razliku od oštećenja koja su nastala nakon izlaganja izofluranu. Izofluran je uzrokovao najvišu razinu 
primarnih  oštećenja DNA u bubrežnim stanicama dva sata nakon izlaganja, a nakon toga zamijećen je pad razine oštećenja 
DNA, koji upućuje na njihov učinkovit popravak. Međutim, niti nakon 24 sata od izlaganja nije zamijećeno potpuno 
vraćanje razine oštećenja DNA na kontrolne vrijednosti. Zaključeno je da je sevofluran u uvjetima pokusa bio genotoksičniji 
od izoflurana. Prema dobivenim rezultatima, inhalacijski anestetici koji se trenutačno koriste, sevofluran i izofluran, mogu 
uzrokovati oštećenja DNA u bubrežnim stanicama miša. Slični učinci mogli bi se očekivati i u ljudi, pa se ta činjenica 
mora uzeti u obzir u svakodnevnoj kliničkoj praksi.
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